BIOMAT Database Logo BIOMAT Database Logo

[Comparative studies on colimycin, neomycin and mycerin and chemical method of determination of colimycin]. 1956

M F LAVROVA

UI MeSH Term Description Entries
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D003091 Colistin Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Polymyxin E,Colimycin,Colisticin,Colistin Sulfate,Coly-Mycin,Totazina,Sulfate, Colistin
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics

Related Publications

M F LAVROVA
[Comparative pharmacological studies on colimycin, mycerin and neomycin].
January 1958, Antibiotiki,
M F LAVROVA
[COMPARATIVE STUDIES ON SOME PHYSICO-CHEMICAL PROPERTIES OF COLIMYCIN, MYCERIN AND NEOMYCIN].
August 1964, Antibiotiki,
M F LAVROVA
[COMPARATIVE STUDIES ON NEOMYCIN, COLIMYCIN AND MYCERIN BY MEANS OF THE COUNTER-CURRENT DISTRIBUTION METHOD].
December 1963, Antibiotiki,
M F LAVROVA
[STUDIES OF DECOMPOSITION PRODUCTS OF COLIMYCIN, MYCERIN AND NEOMYCIN].
September 1964, Antibiotiki,
M F LAVROVA
[Study of the strains of dysenterial bacteria resistant to neomycin (colimycin, mycerin) and monomycin].
June 1967, Antibiotiki,
M F LAVROVA
[Colimycin and mycerin therapy of acute dysentery].
January 1958, Antibiotiki,
M F LAVROVA
[COMPARISON OF COLIMYCIN, MYCERIN AND NEOMYCIN BY THEIR CHROMATOGRAPHIC BEHAVIOR AND CONTENT OF COMPONENTS OF THE COMPONENT B AND C].
November 1964, Antibiotiki,
M F LAVROVA
[Effectiveness of mycerin and colimycin in severe forms of coli enteritis].
March 1962, Voprosy okhrany materinstva i detstva,
M F LAVROVA
[The use of colimycin, mycerin and monomycin for treatment of surgical diseases].
January 1961, Vestnik Akademii meditsinskikh nauk SSSR,
M F LAVROVA
[On the problem of neomycin (colimycin) effect on gastric secretion].
November 1965, Antibiotiki,
Copied contents to your clipboard!